How many companies in cities across Suffolk County received FDA citations in Q4 2024?

How many companies in cities across Suffolk County received FDA citations in Q4 2024?
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) — Official website
0Comments

There was one company in a city associated with Suffolk County that received FDA citations as a result of one inspection conducted in the county over the fourth quarter of 2024, according to reports from the U.S. Food and Drug Administration (FDA).

This is a 66.7% decrease from the number of companies cited in the previous quarter.

The citations in the county include:

  • Written procedures have not been developed for the surveillance of post marketing adverse drug experiences.
  • Adverse drug experience information obtained or otherwise received from any source was not promptly reviewed, including information from commercial marketing experience.
  • Not all adverse drug experiences that are both serious and unexpected have been reported to FDA within 15 calendar days of initial receipt of the information.

The company cited should take a voluntary action to correct its managing operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.

Companies located within Suffolk County Cities and the citations they received in Q4 2024
Company Name Area of Business Inspection Date Issue Cited
Alexion Pharmaceuticals, Inc. Drugs 11/07/2024 Failure to develop written procedures
Alexion Pharmaceuticals, Inc. Drugs 11/07/2024 Failure to review ADE information
Alexion Pharmaceuticals, Inc. Drugs 11/07/2024 Late submission of 15-day report
Alexion Pharmaceuticals, Inc. Drugs 11/07/2024 Late submission of an ICSR


Related

U.S. Rep. Ayanna Pressley Massachusetts 7th District

Ayanna Pressley announces House passage of TPS extension for Haiti

Congresswoman Ayanna Pressley announced via social media posts on April 16-17 that the House passed an extension for TPS for Haiti with bipartisan support.

U.S. Rep. Ayanna Pressley Massachusetts 7th District

Ayanna Pressley reports progress on extending Temporary Protected Status for Haiti

Congresswoman Ayanna Pressley announced via Twitter a series of legislative victories advancing her push to extend Temporary Protected Status for Haiti between April 15-16, 2026.

U.S. Rep. Ayanna Pressley Massachusetts 7th District

Ayanna Pressley addresses food insecurity and immigration policy concerns

Congresswoman Ayanna Pressley used her social media accounts on April 10-11, 2026 to discuss rising food insecurity rates in Massachusetts and urge action on extending TPS protections for Haitians living locally.